BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16264882)

  • 1. Perspectives in the treatment of gastric cancer.
    Roukos DH; Kappas AM
    Nat Clin Pract Oncol; 2005 Feb; 2(2):98-107. PubMed ID: 16264882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended lymphadenectomy in gastric cancer: when, for whom and why.
    Roukos DH
    Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
    Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
    Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal locoregional treatment in gastric cancer.
    Jansen EP; Boot H; Verheij M; van de Velde CJ
    J Clin Oncol; 2005 Jul; 23(20):4509-17. PubMed ID: 16002841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal surgery for advanced gastric cancer.
    Songun I; van de Velde CJ
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1849-58. PubMed ID: 19954295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
    Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
    McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
    Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
    Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
    Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
    Bottke D; Wiegel T; Kreienberg R; Kurzeder C; Sauer G
    Strahlenther Onkol; 2007 Nov; 183(11):600-4. PubMed ID: 17960334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
    Le A; Berger D; Lau M; El-Serag HB
    Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
    Shah MA; Kelsen DP
    Chirurg; 2002 Apr; 73(4):325-30. PubMed ID: 12063916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
    Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodal therapy in locally advanced gastric cancer].
    Bölke E; Peiper M; Knoefel WT; Baldus SE; Schauer M; Matuschek C; Gerber PA; Hoff NP; Budach W; Gattermann N; Erhardt A; Scherer A; Buhren BA; Orth K
    Dtsch Med Wochenschr; 2011 Oct; 136(43):2205-11. PubMed ID: 22009175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.